These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

807 related items for PubMed ID: 8633584

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F, Moum B, Haug JB, Tolås P, Breder O, Aubert E, Høie O, Søberg T, Flaaten B, Farup P, Berge T.
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [Abstract] [Full Text] [Related]

  • 25. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D, Tangkijvanich P, Treeprasertsuk S, Wisedopas N, Kullavanijaya P.
    J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
    Kaviani MJ, Malekzadeh R, Vahedi H, Sotoudeh M, Kamalian N, Amini M, Massarrat S.
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):915-9. PubMed ID: 11507355
    [Abstract] [Full Text] [Related]

  • 28. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M, Székely E, Illyés G, Széles I.
    Orv Hetil; 2000 Jul 30; 141(31):1711-4. PubMed ID: 10976194
    [Abstract] [Full Text] [Related]

  • 29. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.
    Wilhelmsen I, Weberg R, Berstad K, Hausken T, Hundal O, Berstad A.
    Hepatogastroenterology; 1994 Feb 30; 41(1):43-7. PubMed ID: 8175114
    [Abstract] [Full Text] [Related]

  • 30. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
    Kung NN, Sung JJ, Yuen NW, Ng PW, Wong KC, Chung EC, Lim BH, Choi CH, Li TH, Ma HC, Kwok SP.
    Am J Gastroenterol; 1997 Mar 30; 92(3):438-41. PubMed ID: 9068464
    [Abstract] [Full Text] [Related]

  • 31. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH, Yeung CK, Lee KH.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):81-6. PubMed ID: 16803605
    [Abstract] [Full Text] [Related]

  • 32. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD, Morton D, Perry MJ, Sanders DS, Morris P, Rowland A, Thompson M, Mitchell TR, Roberts PM.
    Aliment Pharmacol Ther; 2001 Aug 01; 15(8):1199-204. PubMed ID: 11472323
    [Abstract] [Full Text] [Related]

  • 33. [10 days of triple treatment of Helicobacter pylori infection and peptic ulcer. Status after treatment of 4 weeks and of one year].
    Berstad A, Berstad K, Hatlebakk JG, Wilhelmsen I, Nysaeter G, Bang CJ, Hausken T, Nesje LB, Hjartholm AS, Hundal O.
    Tidsskr Nor Laegeforen; 1994 Sep 10; 114(21):2477-9. PubMed ID: 7940447
    [Abstract] [Full Text] [Related]

  • 34. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT, Ramirez FC, Lew GM, Genta RM, Graham DY.
    Am J Gastroenterol; 1994 Aug 10; 89(8):1203-5. PubMed ID: 8053435
    [Abstract] [Full Text] [Related]

  • 35. The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation.
    Zojaji H, Talaie R, Mirsattari D, Haghazali M, Molaei M, Mohsenian N, Derakhshan F, Zali MR.
    Dig Liver Dis; 2009 Sep 10; 41(9):644-7. PubMed ID: 19493713
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M, Tsuda M, Okita K, Sugiyama T, Nakazawa T.
    Eur J Gastroenterol Hepatol; 1995 Aug 10; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [Abstract] [Full Text] [Related]

  • 37. [Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
    Wilhelmsen I, Hundal O, Berstad K, Berstad A.
    Tidsskr Nor Laegeforen; 1992 Oct 20; 112(25):3197-9. PubMed ID: 1462293
    [Abstract] [Full Text] [Related]

  • 38. A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates.
    Sotudehmanesh R, Malekzadeh R, Fazel A, Massarrat S, Ziad-Alizadeh B, Eshraghian MR.
    J Gastroenterol Hepatol; 2001 Mar 20; 16(3):264-8. PubMed ID: 11339416
    [Abstract] [Full Text] [Related]

  • 39. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
    Gisbert JP, Gisbert JL, Marcos S, Grávalos RG, Carpio D, Pajares JM.
    Aliment Pharmacol Ther; 1999 Oct 20; 13(10):1311-6. PubMed ID: 10540045
    [Abstract] [Full Text] [Related]

  • 40. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
    Catalano F, Branciforte G, Catanzaro R, Cipolla R, Bentivegna C, Brogna A.
    Aliment Pharmacol Ther; 2000 Oct 20; 14(10):1329-34. PubMed ID: 11012478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.